Citius Pharmaceuticals, Inc. (CTXR)

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 8, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	74	109	177	296	58	22
Market Cap Growth	-44.68%	-38.51%	-40.33%	413.63%	164.13%	-21.14%
Enterprise Value	52	77	130	182	51	18
Last Close Price	0.38	0.68	1.21	2.03	1.04	0.76
PE Ratio	-	-3.07	-5.25	-9.00	-2.32	-0.98
PB Ratio	0.81	1.19	1.71	2.23	1.71	0.80
P/FCF Ratio	-3.63	-3.74	-6.23	-12.22	-3.41	-1.76
P/OCF Ratio	-3.63	-3.74	-6.23	-12.22	-3.41	-1.76
EV/EBITDA Ratio	-2.29	-2.08	-3.91	-7.75	-2.86	-1.12
EV/EBIT Ratio	-2.29	-2.08	-3.90	-7.75	-2.86	-1.12
EV/FCF Ratio	-3.23	-2.64	-4.59	-7.52	-2.99	-1.41
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.04	0.01
Debt / FCF Ratio	-0.01	-0.02	-0.02	-0.04	-0.08	-0.01
Quick Ratio	4.31	4.58	9.21	17.60	3.38	1.71
Current Ratio	6.75	5.95	9.84	18.28	3.41	1.72
Return on Equity (ROE)	-41.49%	-33.40%	-28.48%	-27.70%	-57.70%	-56.57%
Return on Assets (ROA)	-24.74%	-21.10%	-16.24%	-15.80%	-27.49%	-28.76%
Return on Capital (ROIC)	-27.68%	-23.42%	-17.52%	-17.44%	-35.51%	-35.22%
Earnings Yield	-52.34%	-29.93%	-19.03%	-7.78%	-30.42%	-71.24%
FCF Yield	-38.29%	-26.73%	-16.04%	-8.19%	-29.35%	-56.94%
Buyback Yield / Dilution	-9.86%	-3.57%	-34.52%	-177.28%	-94.25%	-87.87%
Total Shareholder Return	-9.86%	-3.57%	-34.52%	-177.28%	-94.25%	-87.87%

Source: S&P Capital IQ. Standard template. Financial Sources.